SPRUCE BIOSCIENCES, INC. Quarterly Debt-to-equity in % from Q2 2021 to Q2 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Spruce Biosciences, Inc. quarterly Debt-to-equity history and growth rate from Q2 2021 to Q2 2024.
Spruce Biosciences, Inc. Debt-to-equity for the quarter ending June 30, 2024 was 32.1 %, a 19.3% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q2 2024	32.1	+5.2	+19.3%	Jun 30, 2024
Q1 2024	32.4	+9.02	+38.6%	Mar 31, 2024
Q4 2023	31.5	+12.5	+65.4%	Dec 31, 2023
Q3 2023	29.4	+13	+79.4%	Sep 30, 2023
Q2 2023	26.9	+12.5	+86.5%	Jun 30, 2023
Q1 2023	23.4	+10.7	+84.3%	Mar 31, 2023
Q4 2022	19.1	+7.69	+67.6%	Dec 31, 2022
Q3 2022	16.4	+6.1	+59.4%	Sep 30, 2022
Q2 2022	14.4	-0.37	-2.5%	Jun 30, 2022
Q1 2022	12.7			Mar 31, 2022
Q4 2021	11.4			Dec 31, 2021
Q3 2021	10.3			Sep 30, 2021
Q2 2021	14.8			Jun 30, 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.